This controlled study investigates the effects of fractional CO2 laser therapy, both with and without probiotic supplementation, on lactobacilli distribution and vaginal health outcomes. The study is particularly relevant for women suffering from vaginal relaxation syndrome (VRS) and recurrent bacterial vaginitis, conditions that can significantly impact quality of life.
Fractional CO2 laser therapy is believed to enhance the local vaginal microecology by promoting collagen remodeling and epithelial regeneration, creating a favorable environment for lactobacilli colonization. Probiotics, particularly strains like Lactobacillus crispatus and Lactobacillus gasseri, are known to produce lactic acid, which helps maintain an acidic vaginal pH, inhibiting the growth of pathogenic bacteria and supporting overall vaginal health.
While the findings are promising, the study has limitations, including a single-center design and a relatively small sample size, which may affect the generalizability of the results. Additionally, the absence of objective indicators such as muscle strength tests and a broader exploration of other vaginal infections limits the scope of the conclusions drawn.
This study highlights the potential of combining fractional CO2 laser therapy with probiotic supplementation as a non-invasive treatment strategy for improving vaginal health outcomes. The significant improvements in lactobacilli distribution and VHI scores suggest that such integrative approaches could enhance the management of vaginal health issues, ultimately improving the quality of life for affected women.